Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 1;44(3):258-264.
doi: 10.1097/PGP.0000000000001074. Epub 2024 Oct 30.

Bilateral Somatically Derived Germ Cell Tumors With 12p Gains Arising in High-grade Serous Carcinomas of the Ovary: A Case Report and Review of the Literature

Affiliations
Review

Bilateral Somatically Derived Germ Cell Tumors With 12p Gains Arising in High-grade Serous Carcinomas of the Ovary: A Case Report and Review of the Literature

Amr H Masaadeh et al. Int J Gynecol Pathol. .

Abstract

Epithelial ovarian neoplasms are commonly observed in older patients, while germ cell tumors (GCTs) typically present in young individuals. When GCTs are detected in patients over 35 yrs old, they often have an associated epithelial component, a phenomenon known as somatically derived GCTs. We report a unique case of mixed GCT involving bilateral ovaries with a background of high-grade serous carcinoma, including a yolk sac tumor and choriocarcinoma in the mixed GCT component. Somatically derived GCTs are rare with only 45 cases of ovarian carcinoma with somatic yolk sac tumor reported to date. Pathologists face diagnostic challenges in identifying somatically derived GCTs, as they can mimic high-grade epithelial neoplasms. Somatically derived GCTs have poor outcomes, therefore, precise diagnosis is crucial for prognostic and therapeutic considerations.

Keywords: 12p gain; High-grade serous carcinoma; Mixed germ cell tumors; Ovarian tumors; Somatically derived.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Sviracevic B, Sedlar S, Malobabic D, et al. Mixed malignant germ cell tumor of ovary. Med Pregl 2011;64:93–95.
    1. Zuntová A, Sumerauer D, Teslík L, et al. Mixed germ cell tumours of the ovary in childhood and adolescence. Cesk Patol 2004;40:92–101.
    1. Gershenson DM, Sun CC, Lu KH, et al. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol 2006;108:361–368.
    1. Nogales FF, Prat J, Schuldt M, et al. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells. Histopathology 2018;72:634–647.
    1. Skala SL, Liu CJ, Udager AM, et al. Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation. Mod Pathol 2020;33:1989–2000.

MeSH terms